摘要 |
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, X1, X2, X3, L1 and L2 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof in such a treatment. |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;MANTOULIDIS, ANDREAS;DAHMANN, GEORG;ETTMAYER, PETER;KLEIN, CHRISTIAN;STEURER, STEFFEN;WAIZENEGGER, IRENE;ZAHN, STEPHAN KARL |
发明人 |
MANTOULIDIS, ANDREAS;DAHMANN, GEORG;ETTMAYER, PETER;KLEIN, CHRISTIAN;STEURER, STEFFEN;WAIZENEGGER, IRENE;ZAHN, STEPHAN KARL |